Franziska K Lorbeer

7PUBLICATIONS
54CO-AUTHORS
Predictive and prognostic markersMolecular targetsGene and molecular therapyEpigenetics (incl. genome methylation and epigenomics)Reaction engineering (excl. nuclear reactions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 19, 2024
Distinct senescence mechanisms restrain progression of dysplastic nevi.

Franziska K Lorbeer, Gabrielle Rieser, Aditya Goel

|Jul 28, 2023
Distinct senescence mechanisms restrain progression of dysplastic nevi.

Franziska K Lorbeer, Gabrielle Rieser, Aditya Goel

|Oct 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in Glioblastoma.

Sied Kebir, Vivien Ullrich, Pia Berger

|Apr 14, 2022
Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita.

Seunga Choo, Franziska K Lorbeer, Samuel G Regalado

|Dec 01, 2020
TINF2 is a haploinsufficient tumor suppressor that limits telomere length.

Isabelle Schmutz, Arjen R Mensenkamp, Kaori K Takai

|Apr 17, 2019
Transient activation of the UPRER is an essential step in the acquisition of pluripotency during reprogramming.

Milos S Simic, Erica A Moehle, Robert T Schinzel

Pageof 2